Skip to main content
. 2013 Jun 28;16(2):159–163. doi: 10.4048/jbc.2013.16.2.159

Table 2.

Levels of erythrocyte membrane Na+-K+-ATPase activity and pLCAT activity in control and patients groups

graphic file with name jbc-16-159-i002.jpg

Data are presented as mean±SD. Comparisons are made between control and breast cancer subjects. p<0.001 vs. control group and before treatment. p<0.001 vs. control group and after treatment. p<0.001 vs. after treatment and before treatment.

pLCAT=plasma lecithin:cholesterol acyltransferase.